PreprintAll rights reservedmedRxiv
Optimising HPV Vaccination for Cervical Cancer Prevention in Women Living with HIV: A Cost-Effectiveness Analysis Across 13 African Countries
- 1Public Health Modelling Team, IPT-BIMS, Institut Pasteur de Tunis, Tunis, Tunisia
Related
- Target trial emulation of effectiveness of COVID-19 mRNA vaccination during pregnancy in four European countries
- Optimising a national screen-and-treat cervical cancer strategy in Uganda: a microsimulation cost-effectiveness and budget impact analysis.
- Hepatitis B vaccination coverage and factors associated with higher uptake among children aged 5–35 months in eight selected sub-Saharan African countries: a multilevel ordinal logistic regression analysis
- Impact of HPV vaccination on high-risk HPV prevalence in 25-29-year-old women attending cervical screening in England 2016-2025
- The Role of Self-Collection in Optimising Cervical Screening for People With Intellectual Disability: A Multi Perspective Qualitative Study.
BibTeX
@misc{miled2026optimising,
title = {{Optimising HPV Vaccination for Cervical Cancer Prevention in Women Living with HIV: A Cost-Effectiveness Analysis Across 13 African Countries}},
author = {S. Ben Miled and S. Trabelsi and K. Abbas and T. A. Holryod and C. L. Trotter},
howpublished = {medRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.05.26364501},
url = {https://www.medrxiv.org/content/10.64898/2026.10.05.26364501v1},
}
RIS
TY - UNPB
TI - Optimising HPV Vaccination for Cervical Cancer Prevention in Women Living with HIV: A Cost-Effectiveness Analysis Across 13 African Countries
AU - S. Ben Miled
AU - S. Trabelsi
AU - K. Abbas
AU - T. A. Holryod
AU - C. L. Trotter
PY - 2026
DA - 2026/10/05
PB - medRxiv
DO - 10.64898/2026.10.05.26364501
UR - https://www.medrxiv.org/content/10.64898/2026.10.05.26364501v1
ER -